USANA Health Sciences (NYSE:USNA – Get Free Report) released its quarterly earnings data on Tuesday. The company reported $0.64 earnings per share for the quarter, topping analysts’ consensus estimates of $0.49 by $0.15, Zacks reports. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. USANA Health Sciences updated its FY 2025 guidance to 2.350-3.000 EPS.
USANA Health Sciences Stock Down 2.4 %
NYSE USNA traded down $0.79 during trading on Tuesday, hitting $31.90. 439,916 shares of the stock traded hands, compared to its average volume of 145,134. USANA Health Sciences has a 12-month low of $30.13 and a 12-month high of $50.32. The firm has a 50-day simple moving average of $33.73 and a 200-day simple moving average of $36.68. The company has a market capitalization of $607.96 million, a P/E ratio of 11.27, a price-to-earnings-growth ratio of 0.93 and a beta of 0.87.
Analyst Upgrades and Downgrades
USNA has been the subject of several recent analyst reports. DA Davidson upped their price target on USANA Health Sciences from $35.00 to $38.00 and gave the stock a “neutral” rating in a research note on Thursday, January 2nd. StockNews.com lowered shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research report on Friday, February 14th. Finally, Sidoti downgraded shares of USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a report on Tuesday, February 18th.
About USANA Health Sciences
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
Featured Articles
- Five stocks we like better than USANA Health Sciences
- Airline Stocks – Top Airline Stocks to Buy Now
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- Do ETFs Pay Dividends? What You Need to Know
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.